TCT 202: Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: First Patient-Level Pooled Analysis Comprising Randomized IRONMAN-II Trial and Prospective IRONMAN-III Registry
We Recommend
Disclosures
<p>Nothing to disclose</p>
New at TCTMD? Register today!
Enter the email you used to register to reset your password.